(IR) Ingersoll Rand - NYSE
Sector: Industrials | Industry: Specialty Industrial Machinery | Exchange: NYSE (USA) | Market Cap: 30.489m USD | Total Return: -6.3% in 12m
Avg Turnover: 294M
EPS Trend: 84.3%
Qual. Beats: 0
Rev. Trend: 98.6%
Qual. Beats: 0
Warnings
Choppy
Tailwinds
No distinct edge detected
Ingersoll Rand Inc. (NYSE: IR) is a diversified industrial manufacturer providing mission-critical air, fluid, clean energy, and medical technologies and services worldwide. Founded in 1859 and headquartered in Davidson, North Carolina, the company operates through two reportable segments: Industrial Technologies and Services and Precision and Science Technologies.
The Industrial Technologies and Services segment designs, manufactures, and services air and gas compression and treatment equipment, vacuum and blower products, fluid transfer equipment, loading systems, and power tools and lifting equipment under brands such as Ingersoll Rand, Gardner Denver, Nash, CompAir, and Elmo Rietschle. The Precision and Science Technologies segment produces diaphragm, piston, water-powered, peristaltic, gear, vane, progressive cavity, and syringe pumps, along with hydrogen compression systems, liquid handling systems, and odorant injection systems under brands including ARO, Dosatron, Haskel, Milton Roy, Seepex, Thomas, Welch, and Williams. Products are sold through a mix of direct sales representatives and independent distributors, serving end markets such as medical, laboratory, industrial manufacturing, water and wastewater, chemical processing, clean energy, food and beverage, and agriculture.
The company maintains a strategic alliance with Garrett Motion and was formerly known as Gardner Denver Holdings, Inc., rebranding to Ingersoll Rand in March 2020. As a participant in the industrial machinery and components subsector, the business combines original equipment manufacturing with aftermarket parts, consumables, and service offerings, a model that typically generates recurring revenue tied to its global installed base.
- Data center expansion boosts compressor and blower orders
- Bolt-on M&A pipeline expands precision pump and clean energy platforms
- Aftermarket service revenue drives margin expansion and recurring growth
| Net Income: 587.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -1.41 > 1.0 |
| NWC/Revenue: 30.38% < 20% (prev 34.67%; Δ -4.30% < -1%) |
| CFO/TA 0.07 > 3% & CFO 1.30b > Net Income 587.0m |
| Net Debt (3.63b) to EBITDA (1.66b): 2.19 < 3 |
| Current Ratio: 2.23 > 1.5 & < 3 |
| Outstanding Shares: last quarter (392.0m) vs 12m ago -3.72% < -2% |
| Gross Margin: 38.24% > 18% (prev 43.80%; Δ -5.56% > 0.5%) |
| Asset Turnover: 42.52% > 50% (prev 39.62%; Δ 2.90% > 0%) |
| Interest Coverage Ratio: 4.55 > 6 (EBIT TTM 1.17b / Interest Expense TTM 256.5m) |
| A: 0.13 (Total Current Assets 4.29b - Total Current Liabilities 1.93b) / Total Assets 18.2b |
| B: 0.18 (Retained Earnings 3.24b / Total Assets 18.2b) |
| C: 0.06 (EBIT TTM 1.17b / Avg Total Assets 18.3b) |
| D: 1.28 (Book Value of Equity 10.2b / Total Liabilities 7.98b) |
| Altman-Z'' = 3.20 = A |
| DSRI: 1.01 (Receivables 1.46b/1.35b, Revenue 7.78b/7.28b) |
| GMI: 1.15 (GM 43.80% / 38.24%) |
| AQI: 1.00 (AQ_t 0.71 / AQ_t-1 0.72) |
| SGI: 1.07 (Revenue 7.78b / 7.28b) |
| TATA: -0.04 (NI 587.0m - CFO 1.30b) / TA 18.2b) |
| Beneish M = -2.84 (Cap -4..+1) = A |
As of June 26, 2026, the stock is trading at USD 78.32 with a total of 4,527,853 shares traded. Over the past week, the price has changed by -0.25%, over one month by +8.13%, over three months by -5.78% and over the past year by -6.32%.
Current recommended Stop Loss: 73.30 (which is 6.4% or 2 ATR below the current price).
Ingersoll Rand has received a consensus analysts rating of 3.94. Therefore, it is recommended to buy IR.
- StrongBuy: 7
- Buy: 2
- Hold: 8
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 93.2 | 19% |
P/E Trailing = 52.6419
P/E Forward = 22.5225
P/S = 3.9182
P/B = 2.9964
P/EG = 0.7431
Revenue TTM = 7.78b USD
EBIT TTM = 1.17b USD
EBITDA TTM = 1.66b USD
Long Term Debt = 4.78b USD (from longTermDebt, last quarter)
Short Term Debt = 66.2m USD (from shortTermDebt, last quarter)
Debt = 4.91b USD (from shortLongTermDebtTotal, last quarter) + Leases 64.8m
Net Debt = 3.63b USD (calculated: Debt 4.91b - CCE 1.27b)
Enterprise Value = 34.1b USD (30.5b + Debt 4.91b - CCE 1.27b)
Interest Coverage Ratio = 4.55 (Ebit TTM 1.17b / Interest Expense TTM 256.5m)
EV/FCF = 29.40x (Enterprise Value 34.1b / FCF TTM 1.16b)
FCF Yield = 3.40% (FCF TTM 1.16b / Enterprise Value 34.1b)
FCF Margin = 14.92% (FCF TTM 1.16b / Revenue TTM 7.78b)
Net Margin = 7.54% (Net Income TTM 587.0m / Revenue TTM 7.78b)
Gross Margin = 38.24% ((Revenue TTM 7.78b - Cost of Revenue TTM 4.81b) / Revenue TTM)
Gross Margin QoQ = 42.90% (prev 24.06%)
Tobins Q-Ratio = 1.87 (Enterprise Value 34.1b / Total Assets 18.2b)
Interest Expense / Debt = 5.23% (Interest Expense 256.5m / Debt 4.91b)
Taxrate = 24.90% (197.0m / 791.2m)
NOPAT = 876.3m (EBIT 1.17b * (1 - 24.90%))
Current Ratio = 2.23 (Total Current Assets 4.29b / Total Current Liabilities 1.93b)
Debt / Equity = 0.48 (Debt 4.91b / totalStockholderEquity, last quarter 10.2b)
Debt / EBITDA = 2.19 (Net Debt 3.63b / EBITDA 1.66b)
Debt / FCF = 3.13 (Net Debt 3.63b / FCF TTM 1.16b)
Total Stockholder Equity = 10.1b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.21% (Net Income 587.0m / Total Assets 18.2b)
RoE = 5.80% (Net Income TTM 587.0m / Total Stockholder Equity 10.1b)
RoCE = 7.83% (EBIT 1.17b / Capital Employed (Equity 10.1b + L.T.Debt 4.78b))
RoIC = 5.49% (NOPAT 876.3m / Invested Capital 16.0b)
WACC = 9.23% (E(30.5b)/V(35.4b) * Re(10.08%) + D(4.91b)/V(35.4b) * Rd(5.23%) * (1-Tc(0.25)))
Discount Rate = 10.08% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -84.11 | Cagr: -1.78%
[DCF] Terminal Value 69.88% ; FCFF base≈1.27b ; Y1≈1.11b ; Y5≈898.9m
[DCF] Fair Price = 22.93 (EV 12.6b - Net Debt 3.63b = Equity 8.97b / Shares 391.3m; r=9.23% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 84.32 | EPS CAGR: 7.09% | SUE: 0.79 | # QB: 0
Revenue Correlation: 98.60 | Revenue CAGR: 6.16% | SUE: 0.58 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.82 | Chg30d=-0.33% | Revisions=-33% | Analysts=15
EPS next Quarter (2026-09-30): EPS=0.91 | Chg30d=-0.30% | Revisions=-33% | Analysts=15
EPS current Year (2026-12-31): EPS=3.50 | Chg30d=+0.00% | Revisions=+0% | GrowthEPS=+4.9% | GrowthRev=+3.8%
EPS next Year (2027-12-31): EPS=3.84 | Chg30d=-0.05% | Revisions=-33% | GrowthEPS=+9.8% | GrowthRev=+4.6%
[Analyst] Revisions Ratio: -33%